B. Riley Securities, Inc. Journey Medical Corp Call Options Transaction History
B. Riley Securities, Inc.
- $460 Billion
- Q4 2022
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding DERM
# of Institutions
41Shares Held
5.89MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$13.4 Million0.71% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT931KShares$6.74 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA372KShares$2.7 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.338KShares$2.45 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny238KShares$1.72 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $84M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...